TopFunds

Fortive

NYSE: FTV

Stock price

61.81 USD

(+0%) TODAY

Industrial Machinery & Supplies & ComponentsIndustrial - Machinery

Financial Performance

Share

5Y price score: 10

Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

10Y return: 91.7%

DATE RANGE:

US$ Per
Share

    Time scale:

    By default your notes are visible only to you.

    46.5

    52-week range

    64.5

    61.81

    Your model inputs

    Required return / cost of capital
    %
    FCFF terminal growth rate
    %

    Your fair value & Margin of safety

    To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

    Forecast:

    Valuation

    Free Cash Flow Yield

    Help
    FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

    4.9 %

    Dividend Yield TTM

    0.4 %

    Market cap $

    $ 18,668

    Price / Earnings TTM

    Help
    P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

    36.4

    Price / Book TTM

    3.1

    PEG TTM

    Help
    Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

    (1.4)

    Earnings growth and return

    LTM

    5YR

    10YR

    Total return (price & dividends)

    27.3 %

    9.9 %

    91.7 %

    Free cash flow per share growth

    (23.2) %

    (19.2) %

    18.9 %

    Earnings per share growth

    (26.3) %

    (59.5) %

    (30.4) %

    Founded: 2,016

    Employees: 10,000

    Business Summary:Fortive Corporation is a global industrial technology company that specializes in the conception, development, manufacturing, marketing, and servicing of sophisticated professional and engineered products, as well as software platforms and associated services. Its Intelligent Operating Solutions division aims to boost efficiency and safety in operations. This segment delivers a variety of offerings, including advanced tools for ensuring equipment reliability, comprehensive enterprise software for managing environmental, health, safety, and quality (EHSQ) compliance, and specialized software for the entire lifecycle of facilities and assets. It also provides solutions for pre-construction planning and procurement, robust professional testing instruments, precise calibration tools for electrical, pressure, and temperature measurements, and portable devices for gas detection. These products and services cater to diverse industries such as manufacturing, process industries, healthcare, utilities and power generation, communications, and electronics. Key brands within this segment include ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL. The company's Precision Technologies segment focuses on delivering critical measurement and control solutions. Its portfolio encompasses electrical testing and measurement instruments and related services, high-performance energetic material devices, and advanced sensor and control system solutions. These technologies are crucial for demanding sectors like power and energy management, medical equipment manufacturing, food and beverage production, aerospace and defense, off-highway vehicles, electronics, semiconductor fabrication, and various other industrial applications. This segment markets its offerings under brands such as ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX. Fortive's Advanced Healthcare Solutions division provides a comprehensive suite of hardware, software, and services specifically designed for the healthcare sector. This includes solutions for reprocessing and tracking medical instruments and devices, specialized biomedical testing tools, systems for radiation safety monitoring, and asset management services. Additionally, it offers subscription-based surgical inventory management platforms that optimize inventory and ensure regulatory adherence, alongside expert technical, analytical, and compliance services focused on determining radiation exposure. Brands in this segment include ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, RAYSAFE, and STERRAD. Established in 2015, Fortive Corporation maintains its corporate headquarters in Everett, Washington.

    Fair Value Reference Estimate

    Latest Earnings Call Takeaways

    2026 Q2 (Jul 29, 2026)

    1) Strong Financial Performance
    - Fortive reported Q2 2026 consolidated revenue of nearly $1.1 billion, up almost 8% YoY and 6.7% on a core basis.
    - Adjusted EBITDA grew 12% YoY to $323 million, with an adjusted EBITDA margin of 29.5%, up 110 basis points YoY.
    - Adjusted EPS reached $0.74, marking a 28% increase YoY, continuing a trend of double-digit growth for four consecutive quarters.
    - Free cash flow for Q2 was approximately $270 million, contributing to a trailing 12-month free cash flow of over $1 billion.

    2) Fortive Accelerated Strategy Execution
    - The company is focused on three pillars: driving faster profitable organic growth, disciplined capital allocation, and maintaining investor trust.
    - Investments in innovation and customer value are yielding results, with strong demand for new products like CertiFiber Max and AI-enabled solutions.
    - Fortive executed a small bolt-on acquisition and repurchased approximately $200 million worth of shares, totaling about 38 million shares or 11% of shares since the launch of New Fortive.
    - The full-year adjusted EPS guidance has been raised to $2.95 to $3.05, reflecting confidence in business trajectory.

    3) Segment Performance Insights
    - Intelligent Operating Solutions (IOS): Revenue grew 9% YoY, with core growth of 7.4%. Strong performance in Professional Instrumentation and facility solutions, particularly in North America and APAC.
    - Advanced Healthcare Solutions (AHS): Revenue reached nearly $340 million, up 6% YoY, driven by strong demand for healthcare consumables and software. Adjusted EBITDA was $88 million, up 3% YoY.
    - Both segments experienced slight declines in adjusted gross margins due to product mix dynamics and strategic growth investments.

    4) Market Challenges and Strategic Outlook
    - EMEA revenue declined due to macroeconomic uncertainties, while APAC and LatAm showed strong growth.
    - The company is navigating challenges related to hospital capital expenditure budgets, but improvements are noted in capital equipment demand.
    - Fortive expects Q3 revenue to be in line with historical patterns, with some headwinds anticipated in Q4 due to fewer selling days.
    - The company is focused on maintaining a disciplined approach to capital allocation while pursuing high-quality, accretive bolt-on acquisitions.

    5) Missing Information and Conclusion
    - The transcript lacks specific details on the impact of macroeconomic factors on future guidance and more granular insights into competitive positioning.
    - Bottom line: Fortive's strong Q2 performance and strategic execution reinforce its growth trajectory, with a focus on innovation and disciplined capital allocation positioning the company well for continued shareholder value creation.

    Annual Reports, Presentations And IR Contacts

    Go to the website
    Annual report links (10K)
    2025202420232022202120202019201820172016

    Fortive — Financial Overview, Stock Price, Market Cap

    Fortive is a company. Founded in 2016. As of August 14, 2026, the company's market capitalization is $18667673984 with a current stock price of $61.81.